MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Canna Care Docs

OCTOBER 3, 2023

Alleviating Symptoms with Cannabinoids As more states legalize medical cannabis, many researchers and clinicians are studying the efficacy of cannabinoids like THC and CBD for alleviating these symptoms. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

TheAnswerPage

FEBRUARY 23, 2022

Some clinical studies have evaluated the safety and efficacy of cannabinoid-based medicines for the treatment of autism spectrum disorder (ASD). What are the common adverse events noted in clinical trials examining the efficacy of cannabinoids for ASD? Fletcher S.

Clinical Trials 52

Clinical Trials Events Therapy Sleep 52

MMJ Recs

DECEMBER 28, 2023

Chronic Pain Relief with Medical Marijuana: How Cannabinoids Ease Discomfort Chronic pain is a pervasive issue affecting millions worldwide, and traditional pain medications may not always offer satisfactory relief. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Peninsula Alternative Health

MAY 15, 2019

Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Beneficial side effects included improved mood, better sleep, and increased appetite.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

CannaMD

SEPTEMBER 28, 2020

As if those weren’t enough, the fear of the virus alone can also wreak havoc on sleep patterns. Patients around the world are reporting a sharp increase in sleep problems, and physicians have coined the term coronasomnia to describe the phenomenon. A team of researchers is studying the coronavirus-era sleep crisis.

Sleep 72

Sleep Clinical Trials Patients THC 72

MMJ Recs

NOVEMBER 30, 2023

Studies have indicated that certain cannabinoids found in cannabis, particularly CBD, may have anticonvulsant properties. While anecdotal evidence and individual success stories have sparked interest in using MMJ for seizure control, scientific research plays a crucial role in establishing its safety and efficacy.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. CHARLOTTE, N.C.–(BUSINESS

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

The Joint Blog

JANUARY 23, 2020

.” For this study, “The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted.” One isolated study indicates some potential efficacy for an oral cannabinoid /terpene combination in ADHD. .”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e.,

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

DECEMBER 7, 2021

The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

The Cannigma

MAY 6, 2021

Along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating. (El The cannabis plant can produce a great number of active compounds — those unique to cannabis are called cannabinoids. Interestingly, along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating.

THC 145

THC Cannabinoids Concentrates Hemp 145

Cannabis Law Report

OCTOBER 22, 2021

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. Lenabasum is a novel, oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2) and resolves inflammation and limits fibrosis in animal and human models of disease.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. D8 may well assist with relaxation and sleep. They also sleep better and aren’t as bothered by “Musculo-Skeletal Discomfort”.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

The Cannigma

JANUARY 13, 2023

The ECS touches on nearly every biological function you have, including sleep, pain, appetite, body temperature, immune function, memory, and hormone regulation. Since pain and nausea are two of the most common symptoms of migraines, this cannabinoid is of great scientific interest in helping people who suffer from migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

OCTOBER 18, 2021

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. Lenabasum is a novel, oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2) and resolves inflammation and limits fibrosis in animal and human models of disease.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. Others say if they use before bedtime, they can’t sleep, they stay awake all night. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. How do you standardize for that?

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Joint Blog

APRIL 17, 2020

Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. However, in some cases, the risks may outweigh even the proven benefits.

Events 48

Events THC Chronic Pain Sleep 48

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

MARCH 18, 2021

A fourth group received a placebo with almost zero active cannabinoids. For Veterans With PTSD, Medical Marijuana Can Mean a Good Night’s Sleep. for the production of cannabis used in federally-regulated clinical trials. Another group received an 11% CBD product with minimal THC. Participants were given 1.8

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

JULY 4, 2021

Cannabidiol or CBD is one of the most common cannabinoids found in cannabis. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. When you use these substances, they can impact things like memory, sleep, mood, and pain. What Is CBD?

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Joint Blog

OCTOBER 21, 2020

This includes cannabidiol or CBD, one of the most active cannabinoids found in the plant. Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. With this, hemp byproducts also began to flood the market.

CBD 36

CBD Legalization Oil Hemp 36

Canna Law Blog

APRIL 17, 2020

This can include regulating things like appetite and digestion, motor control, sleep, and muscle and bone growth. For example, the US government conducted studies and found that dogs have many cannabinoid receptors in their cerebellum, brain stem, and medulla oblongata.

Pets 59

Pets Hemp CBD Food 59

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. Datoc, who had obtained a prescription from a naturopath, testified that the marijuana helped him sleep, and stopped his panic attacks and chest pains.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. And in my belief, it should be cannabis, because of the safety profile, number one. and those are intertwined in – they do want THC, but not just THC.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Drug Science. Matthew Johnson. Johns Hopkins University. in/jonathan-sporn-4ba7802/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51